As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
Otsuka will pay $700 million to Transcend shareholders at closing, with an additional $525 million in contingent payments tied to future sales milestones
Subscribe To Our Newsletter & Stay Updated
